tetano
Editor, Senior Moderator
Nat Cancer
. 2022 Apr 4.
doi: 10.1038/s43018-022-00363-4. Online ahead of print.
Outcomes of COVID-19 and risk factors in patients with cancer
Manju Sengar[SUP] #[/SUP][SUP] 1 [/SUP], Girish Chinnaswamy[SUP] #[/SUP][SUP] 1 [/SUP], Priya Ranganathan[SUP] 1 [/SUP], Apurva Ashok[SUP] 1 [/SUP], Shilpushp Bhosale[SUP] 1 [/SUP], Sanjay Biswas[SUP] 1 [/SUP], Pankaj Chaturvedi[SUP] 1 [/SUP], Chetan Dhamne[SUP] 1 [/SUP], Jigeeshu Divatia[SUP] 1 [/SUP], Karishma D'Sa[SUP] 1 [/SUP], Hasmukh Jain[SUP] 1 [/SUP], Sarbani Laskar[SUP] 1 [/SUP], Nirmalya Roy Moulik[SUP] 1 [/SUP], Naveen Mummudi[SUP] 1 [/SUP], Sindhu Nair[SUP] 1 [/SUP], Lingaraj Nayak[SUP] 1 [/SUP], Prakash Nayak[SUP] 1 [/SUP], Shraddha Patkar[SUP] 1 [/SUP], Preeti Pawaskar[SUP] 1 [/SUP], Anant Ramaswamy[SUP] 1 [/SUP], Omshree Shetty[SUP] 1 [/SUP], Arjun Singh[SUP] 1 [/SUP], Epari Sridhar[SUP] 1 [/SUP], Jayashree Thorat[SUP] 1 [/SUP], Rajendra Badwe[SUP] 1 [/SUP], C S Pramesh[SUP] 2 [/SUP], TMH COVID-19 action group
Collaborators, Affiliations
Abstract
Patients with cancer are at higher risk for adverse coronavirus disease 2019 (COVID-19) outcomes. Here, we studied 1,253 patients with cancer, who were diagnosed with severe acute respiratory syndrome coronavirus 2 at a tertiary referral cancer center in India. Most patients had mild disease; in our settings, recent cancer therapies did not impact COVID-19 outcomes. Advancing age, smoking history, concurrent comorbidities and palliative intent of treatment were independently associated with severe COVID-19 or death. Thus, our study provides useful insights into cancer management during the COVID-19 pandemic.
. 2022 Apr 4.
doi: 10.1038/s43018-022-00363-4. Online ahead of print.
Outcomes of COVID-19 and risk factors in patients with cancer
Manju Sengar[SUP] #[/SUP][SUP] 1 [/SUP], Girish Chinnaswamy[SUP] #[/SUP][SUP] 1 [/SUP], Priya Ranganathan[SUP] 1 [/SUP], Apurva Ashok[SUP] 1 [/SUP], Shilpushp Bhosale[SUP] 1 [/SUP], Sanjay Biswas[SUP] 1 [/SUP], Pankaj Chaturvedi[SUP] 1 [/SUP], Chetan Dhamne[SUP] 1 [/SUP], Jigeeshu Divatia[SUP] 1 [/SUP], Karishma D'Sa[SUP] 1 [/SUP], Hasmukh Jain[SUP] 1 [/SUP], Sarbani Laskar[SUP] 1 [/SUP], Nirmalya Roy Moulik[SUP] 1 [/SUP], Naveen Mummudi[SUP] 1 [/SUP], Sindhu Nair[SUP] 1 [/SUP], Lingaraj Nayak[SUP] 1 [/SUP], Prakash Nayak[SUP] 1 [/SUP], Shraddha Patkar[SUP] 1 [/SUP], Preeti Pawaskar[SUP] 1 [/SUP], Anant Ramaswamy[SUP] 1 [/SUP], Omshree Shetty[SUP] 1 [/SUP], Arjun Singh[SUP] 1 [/SUP], Epari Sridhar[SUP] 1 [/SUP], Jayashree Thorat[SUP] 1 [/SUP], Rajendra Badwe[SUP] 1 [/SUP], C S Pramesh[SUP] 2 [/SUP], TMH COVID-19 action group
Collaborators, Affiliations
- PMID: 35379984
- DOI: 10.1038/s43018-022-00363-4
Abstract
Patients with cancer are at higher risk for adverse coronavirus disease 2019 (COVID-19) outcomes. Here, we studied 1,253 patients with cancer, who were diagnosed with severe acute respiratory syndrome coronavirus 2 at a tertiary referral cancer center in India. Most patients had mild disease; in our settings, recent cancer therapies did not impact COVID-19 outcomes. Advancing age, smoking history, concurrent comorbidities and palliative intent of treatment were independently associated with severe COVID-19 or death. Thus, our study provides useful insights into cancer management during the COVID-19 pandemic.